Journal of Reproductive Biotechnology and Fertility Download pdf of this document
The editor of the Journal of Reproductive Biotechnology and Fertility (JRBF) welcome manuscripts in the various areas of reproductive biology and medicine in particular IVF or assisted reproduction and embryonic stem cell technologies, and regeneration medicine related to embryonic stem cell technology. JRBF is an open access online journal (www.ivf-hub.net)
Submitted manuscripts will be considered for publication under the condition they are not being submitted to another journal at the same time and have not been published or accepted by another Journal. Abstracts of full recent papers published in other journals will be accepted if permission was sought from publisher of that journal by the author(s) prior to submission to this journal.
Each issue may contain some or all of the following:
The manuscript is copyrighted and becomes a property of the Journal of Reproductive Biotechnology and Fertility immediately after the authors have transferred copyright to this journal. Such manuscripts may not be reproduced without prior permission from the editor of this journal. Authors may however publish elsewhere or reproduce the abstracts appearing at the beginning of each article without permission.
Electronic submission of manuscripts in point 12 Arial fonts in MS Word format is the only mode of submission accepted at this time. Manuscripts must be submitted electronically to: email@example.com with a cc to: firstname.lastname@example.org
Preparation of Manuscripts
Manuscripts must adhere to American spelling. The manuscript is prepared as per the ICMJE guidelines with a modification pertaining to the reference citation format only. For detailed guidelines please refer to: (http://www.icmje.org/index.html#manuscript). A brief instruction for the authors is given below. Individual components of the manuscript should begin on a new page, in the following sequence:
Submitted manuscript should be accompanied by an electronic covering letter from the author that will be responsible for correspondence regarding the manuscript. This letter must carry the following declaration or statements:
(i) That the study has been approved by competent authorities such as the Institutional Review Board (IRB)
(ii) That studies involving human subjects was performed following written patient informed consent and in compliance to the World Medical Association Declaration of Helsinki.
(iii) That animal studies were approved by competent authorities and that the animal experiments were performed humanely with minimal pain and distress to the animals.
(iv) On conflict of interests (financial and any other commercial interests or gifts received; including sources of financial and material support, and commercial affiliations must be declared).
(v) Another statement indicating the manuscript has been seen and approved by all the authors need also be included.
(vi) The individual author’s contributions and the proportion of the contribution in relation to the overall content of manuscript may also be mentioned at the discretion of the authors.
(vii) Finally a statement indicating permission has been sought from individual(s) if their name(s) was mentioned in the Acknowledgement section or anywhere in the text of the manuscript must be included.
vii. Authors are responsible for all submissions and must retain copies of everything submitted. The publisher shall not be held responsible for human or computer errors resulting in loss of manuscripts during transmission, accidental erasure or was irrecoverable or irretrievable due to computer failure.
viii. Authors are required to provide in their cover letter the names, email addresses and contact details of at least five reviewers.
Language requirement: Authors that are not natives of English must arrange to have their manuscripts edited/copy-edited by the Australian Editorial Services (web: www.nativeenglisheditor.com) prior to submission. The JRBF has contracted and obtained a 20% discount from the Australian Editorial Services (web: www.nativeenglisheditor.com ) for authors of countries from middle and lower income economies. The authors have to obtain a discount code from the Editor’s office if they wish to avail of the discount. Email address:
email@example.com with a cc to the Coordinator at: firstname.lastname@example.org
Manuscripts should be typed double spaced with 3.17cm left/right and 2.54cm top/bottom margins.
The title page must be prepared in the following sequence:
1. The title of the article must be short but sufficiently informative.
The second page should carry an abstract of not more than 300 words. The abstract should state the purposes of the study, basic procedures, core findings and conclusions. Emphasize new and important aspects of the study or observations. Reference to other publications should be avoided.
The text may be divided into sections with the headings:
Introduction, Materials and Methods (or Subjects and Methods), Results and Discussion.
Subheadings will be allowed for long papers.
In this section the purpose of the study should be clearly stated. This shall be followed by the rationale of the study which should be summarized with pertinent references. Do not review extensively.
Materials and Methods:
Describe the rationale for the selection of study subjects (human or experimental animals). The methods employed must be described in detail giving references for documented methods. Laboratory or clinical consumables, paraphernalia, chemicals, reagents, culture media, etc. used in the study must be described succinctly giving manufacturer’s name and address.
Results should be presented in the same chronological sequence as that described for the various experiments or investigations under the methods section above. Repetition in the text of all the data already presented in tables and/or illustrations must be avoided. Do not discuss the results in this section.
Discuss and stress new and crucial findings. Compare or relate your findings to previous observations, if any. Do not make statements that are not supported by your data.
The surname of the author(s) and year of publication should be used when citing previous studies.
The examples given below may be helpful.
(i) Vitrification was estimated to be cheaper than slow cooling (Ali, 1992).
(ii) Ali and Shelton (1993) showed that……………..(note only year need be
mentioned when names of authors are already cited in text).
(iii) Ethylene glycol was reported to be least embryotoxic (Ali and Shelton,
(iii) Glutamine in culture medium overcame developmental blocks (Ali et al.,
(iv) Previous reports (Ali, 1992; Ali and Shelton, 1993; Ali et al., 1993)
You must only acknowledge those that have made significant contributions to your study. The nature of the acknowledged person’s contribution must me mentioned. Acknowledged persons must sign a letter indicating their acceptance to being mentioned in this section.
Organize references in the Reference section in alphabetical order. All authors must be named.
Follow the correct format for citing references as given in the examples below:
Ali J, Whitten WK, Shelton JN. Effect of culture systems on mouse early
embryo development. Hum Reprod. 1993; 8(7):1110 – 4
Coskun S, Qubbaj W, Al-Kabra M, Awartani K, Al-Rejjal R, Al-Hassan S.Multiple displacement amplification efficiency could be improved by removing 2 blastomeres during preimplantation genetic diagnosis. Fertil Steril. 2008; 90(Suppl 1):S302-3.
Ali J, Shelton JN. Development of vitrification solutions. In: Tucker M, Liebermann J, Eds. Vitrification in assisted reproduction. A user’s manual and troubleshooting guide. U K : Informa Healthcare Medical Books, 2 0 0 7 ; 45-63
Ali J. Source of vitrification solution [letter]. Fertil Steril. 2001; 76: 214-5
Ali J. In vitro maturation of immature oocytes in stimulated cycles. Fertil
Steril. In press.
Only standard abbreviations should be used. Please refer to ICMJE guidelines
Tables and Illustrations or Figures:
Each table should be submitted on a separate page and numbered using Arabic numerals consecutively in order of their appearance. Non-standard abbreviations used in tables and illustrations should be explained in footnotes. Figures shall also be numbered in Arabic numerals in the consecutive order of their appearance in the text.
Reprints will not be provided to authors however authors may purchase the same from the editorial office. Email the Editor for further details. Email address: email@example.com with a cc to the Coordinator at : firstname.lastname@example.org
Peer Review Protocol
The author(s) are informed reviewers chosen to review manuscripts shall be required to declare conflicts of interest. Authors may provide the names and email addresses of 4 reviewers that are qualified to review their manuscript so as to facilitate and expedite the peer review process.
The Journal of Reproductive Biotechnology and Fertility (JRBF) shall not be held liable or responsible for any statement made by authors or advertisers. The same rule shall apply to any objection raised due to the use of a person’s name in the manuscript or for that matter to any objection raised against anything printed in this journal. Plagiarism is not permitted by the JRBF. It is the responsibility of authors and advertisers to accept liability/responsibility for their statements and writings.
Download pdf of this document